Abstract
References
1.
1.
Stumvoll M
,
Goldstein BJ
,
van Haeften TW.
Type 2 diabetes: principles of pathogenesis and therapy . Lancet
2005 ;365 :1333 –46 .
2.
2.
Eckel RH
,
Grundy SM
,
Zimmet PZ.
The metabolic syndrome . Lancet
2005 ;365 :1415 –28 .
3.
3.
Staels B.
The clinical significance of PPARα and γ agonism . Br J Diabetes Vasc Dis
2002 ;2 (suppl 1 ):S28 –S31 .
4.
4.
Conlon D.
Goodbye glitazars . Br J Diabetes Vasc Dis
2006 ;6 :135 –7 .
5.
5.
Pourcet B
,
Fruchart J
,
Staels B.
Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis . Expert Opin Emerging Drugs
2006 ;11 :379 –401 .